Latest news
Loading news…
Enumera Molecular
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Ann Arbor, Michigan, United States Founded 2022 11-50 employees For Profit
Enumera Molecular is developing a scalable biomolecule assessment platform enabling lower-cost, rapid clinical liquid biopsy tests.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
19
Patents
8
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 3
- Patents granted
- 8
- Trademarks
- 0
- IT spend
- $303K
Company Info
- Founded
- 2022
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 8
- HQ
- Ann Arbor, Michigan, United States
- Region
- Great Lakes, Midwestern US
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- 0.8
- Trend (30d)
- 1.4
- Trend (90d)
- -0.1
19
professional contacts at Enumera Molecular
Contact execs at Enumera Molecular →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Enumera Molecular
Loading news…
FAQs about Enumera Molecular
People who checked this page also checked these
Browse the full Acquirezy directory.